Open AccessA retrospective study of low-dose apatinib combined with S-1 in patients with advanced non-small cell lung cancer
Author(s) -
Tong Zhou,
Chuyan Wu,
Changsong Zhang,
Peng Li,
Han Dong,
Xiaoyue Zhou,
Hongjun Liu,
Chuang Qi,
Ling Yang
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.05.33
Subject(s) - apatinib , medicine , clinical endpoint , lung cancer , retrospective cohort study , adverse effect , cancer , clinical trial , surgery , oncology , gastroenterology
The current regimens for advanced non-small cell lung cancer (NSCLC) patients are deficient due to failings in standard treatments. This retrospective study aimed to assess the efficacy and safety of low-dose apatinib in combination with S-1 therapy in a NSCLC setting.